Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
Apply
Zanzalintinib
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step